key: cord-0924980-0wkwurbe authors: Xianyu, Yunyan; Wang, Mengmei; Yue, Fang; Xu, Xiaoyu; Yang, Haizhen; Zhao, Dong; Hu, Ke title: One‐year follow‐up of 18 women who infected COVID‐19 while pregnant date: 2022-02-03 journal: J Med Virol DOI: 10.1002/jmv.27628 sha: a0c890fa2db40a2e8860433e984bccf1b080f012 doc_id: 924980 cord_uid: 0wkwurbe Data about the sequelae of women who infected COVID‐19 while pregnant are scarce. We aimed to describe the prevalence of symptoms, pulmonary functions, and radiological changes at a follow‐up of 12 months in 18 pregnant women who developed COVID‐19 at different gestational ages. Our results showed that most women who infected COVID‐19 while pregnant experienced a progressive improvement of their symptoms within 12 months, however, some still had little COVID‐related symptoms but without a reduced quality of life. All their 18 newborns were growing up healthy. Eventually, 18 females agreed to participate and completed the study. The study protocol was reviewed and approved by the Ethics Committee of the Renmin Hospital of Wuhan University (No. WDRY2020-K019) and all participants provided written informed consent. At the first interview, each participant completed a comprehensive questionnaire including demographics, current comorbidities, respiratory and neurological symptoms, and psychological manifestations. Then they were scheduled for analysis of peripheral blood and antibodies for SARS-CoV-2, and for chest CT scans and lung function tests. We also retrospectively collected each pregnant woman's medical information during the hospitalization from the clinical electronic medical record system. Each patient's physical performance was assessed by the modified British Medical Research Council Dyspnoea Scale. 7 The Insomnia Severity Index has evaluated the risk of insomnia and the Hospital Anxiety and Depression Scale 8 has assessed the symptom severity of anxiety and depression. All data were analyzed using SPSS version 25.0 statistical software (IBM Statistics). The medians and interquartile ranges (IQRs) were estimated for quantitative variables with nonnormal distributions, while absolute values and relative frequencies (%) were used for qualitative variables. Statistical comparisons were performed using the χ 2 test, Fisher's exact test, or one-way analysis of variance. A p ˂ 0.05 was considered statistically significant. The main clinical characteristics associated with COVID-19 of the 18 study participants during the acute phase and at follow-up 12 months after COVID-19 are listed in Table 1 . For severity during the acute infection, 18 patients with laboratory-confirmed COVID-19 were classified as mild (n = 3) or moderate (n = 15). Fever, cough, chest tightness, and dyspnea were the most commonly reported symptoms during the acute phase. Myalgia, arthralgia, ageusia, or anosmia were present in some patients. One year later, most of the respiratory symptoms had resolved, although chest tightness, myalgia, arthralgia, anosmia, and/or insomnia occurred in different individual patients (Table 1) . For psychological symptoms, insomnia was reported in 27.8% of the cohort during the acute phase and in 11.1% during convalescence; 33.3% of this cohort reported an increased score on the Hospital Anxiety and Depression Scale during the acute phase, and 22.2% during convalescence. During the follow-up at 12 months, this cohort showed normal spirometer tests. The diffusion lung carbon monoxide (DLCO; reflecting alveolar function) was less than 80% predicted in two cases (74% and 69%, respectively) but more severe impairment (<60%) was not observed (Table 1 and Table S1 ). Abnormal CT findings were found in 83.3% of cases during the acute phase and in 38.9% of cases at follow-up ( Table 2 ). The predominant findings during the acute phase were ground-glass opacity, consolidation, interlobular thickening, and reticular lesions. The main abnormalities at follow-up were mixed nodules with a diameter of 2-4 mm (27.8%), stripe fibrotic lesions (22.2%), and small ground-grass opacities (5.6%) ( Figure S2 ). At follow-up, none had asymptomatic reinfection, and vaccination had not been recommended for them. All 18 mothers tested negative for nucleic acid at nasopharyngeal swabs, and they had high titers of specific serum IgG [37.25 (7.36-87.17) AU/ml, median (IQR)] but all were negative for serum IgM. All children at 1 year are growing up healthy. In this cohort study, we found that a proportion of pregnant women with COVID-19 experienced respiratory symptoms and some of them had psychological consequences 12 months after their hospital discharge. DLCO reduction has been reported as the most common functional alteration in patients with COVID-19 after hospital discharge, 9,10 however, two individuals in this cohort had DLCO less than 80% of predicted at the follow-up of 12 months. COVID-19 has the possibility of sequelae of pulmonary fibrosis, 10 but our 1-year follow-up in this group did not find that they had obvious pulmonary fibrosis on CT. Although abnormal findings were found in 38.9% of this cohort at follow-up, the predominant findings were mixed nodules with a diameter of 2-4 mm and stripe fibrotic lesions. These slight residual imaging findings did not cause the respiratory symptoms, nor did they weaken the lung physiol- Characteristics of and important lessons from the coronavirus disease 2019 (COVID-19) outbreak in China: summary of a report of 72 314 cases from the Chinese Center for disease control and prevention Clinical characteristics of pregnant women with Covid-19 in Wuhan, China Effects of the COVID-19 pandemic on maternal and perinatal outcomes: a systematic review and meta-analysis Maternal and neonatal morbidity and mortality among pregnant women with and without COVID-19 infection. The INTERCOVID Multinational Cohort Study Preeclampsia and COVID-19: results from the INTERCOVID prospective longitudinal study National Health Commission of the People's Republic of China. Diagnosis and Treatment of Novel Coronavirus Infected Pneumonia Standardised questionnaire on respiratory symptoms The validity of the Hospital Anxiety and Depression Scale. An updated literature review Follow-up study of the pulmonary function and related physiological characteristics of COVID-19 survivors three months after recovery 3-Month, 6-month, 9-month, and 12-month respiratory outcomes in patients following COVID-19-related hospitalisation: a prospective study Incidence of post-traumatic stress disorder after coronavirus disease Additional supporting information may be found in the online version of the article at the publisher's website.